FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/063280 [Registered on: 29/02/2024] Trial Registered Prospectively
Last Modified On: 01/02/2025
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Adding new Ultrasound guided blocks help in reducing pain after knee replacement surgeries 
Scientific Title of Study   comparison of analgesic efficacy of ultrasound guided genicular nerve block in combination with femoral nerve block in Primary total knee Arthroplasty  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Madona Stephen 
Designation  Consultant anesthesiologist 
Affiliation  Sparsh Super Specialty Hospital 
Address  Sparsh Super Specialty Hospital 146 Infantry Road Opposite to police commissioners office Bangalore
146 Infantry Road Opposite to police commissioners office Bangalore 560001
Bangalore
KARNATAKA
560001
India 
Phone  9606197707  
Fax  -  
Email  sparshclinical@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Madona Stephen 
Designation  Consultant anesthesiologist 
Affiliation  Sparsh Super Specialty Hospital 
Address  146 Infantry Road Opposite to police commissioners office Bangalore

Bangalore
KARNATAKA
560001
India 
Phone  9606197707  
Fax  -  
Email  madonastephen25@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Soujanya 
Designation  Research Manager 
Affiliation  Sparsh Super Specialty Hospital 
Address  146 Infantry Road Opposite to police commissioners office Bangalore

Bangalore
KARNATAKA
560001
India 
Phone  9606197707  
Fax  -  
Email  soujanya@sparshhospital.com  
 
Source of Monetary or Material Support  
Sparsh Hospital Foundation 146 Infantry Road Opposite to police commissioners office Bangalore Karnataka 560001 
 
Primary Sponsor  
Name  Sparsh Hospital Foundation 
Address  146 Infantry Road Opposite to police commissioners office Bangalore 560001 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Madona  Sparsh Super Speciality Hospital  Department of Anesthesia Third Floor 146 Infantry road opposite to police commissioners office
Bangalore
KARNATAKA 
09606197707
-
soujanya@sparshhospital.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional Ethics committee sparsh Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Group 2: Comparator Arm: Under ultrasound guidance: 0.25% bupivacaine 10 ml as Ipack( injection between popliteal artery and capsule of knee) 0.2 % ropivacaine 10ml +25mcg dexmedetomidine as adductor canal block. 15 ml 0.25 bupivacaine with 8mg dexamethasone ( 5 ml at each genicular nerve - superomedial, superolateral and inferomedial nerve)  CONTROL ARM NAME OF THE PROCEDURE : Ipack( injection between popliteal artery and capsule of knee) + Femoral nerve block DETAILS DOSE: a) 0.25% bupivacaine {BRAND NAME : 0.25%ANAWIN] 10 ml as Ipack( injection between popliteal artery and capsule of knee) b) 0.2 % ropivacaine [BRAND NAME : 0.2% ROPIN] 10ml +25mcg dexmedetomidine [ BRAND NAME :DEXEM] as femoral nerve block. FREQUENCY : single shot injections ROUTE OF ADMINISTRATION: Under ultrasound guidance perineural administration 
Intervention  Group1: Interventional Arm: Under ultrasound guidance: 0.25% bupivacaine 10 ml as Ipack( injection between popliteal artery and capsule of knee) 0.2 % ropivacaine 10ml +25mcg dexmedetomidine as adductor canal block.   INTERVENTION ARM NAME OF THE PROCEDURE : Ipack( injection between popliteal artery and capsule of knee) + Femoral nerve block+ genicular nerve blocks DETAILS DOSE: a) 0.25% bupivacaine {BRAND NAME : 0.25%ANAWIN] 10 ml as Ipack( injection between popliteal artery and capsule of knee) b) 0.2 % ropivacaine [BRAND NAME : 0.2% ROPIN] 10ml +25mcg dexmedetomidine [ BRAND NAME :DEXEM] as femoral nerve block. c) Group I patients will receive 0.25% bupivacaine [ BRAND NAME : 0.25%ANAWIN] 5ml at each genicular nerve ( superomedial, inferomedial, superolateral )with 8mg dexamethasone [ BRAND NAME :DEXONA] in total. FREQUENCY : single shot injections ROUTE OF ADMINISTRATION: Under ultrasound guidance perineural administration  
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Unilateral primary TKA
 
 
ExclusionCriteria 
Details  Poorly Controlled DM(Hba1c>8)
Cirrhosis
Chronic Renal Failure
Stroke , Uncontrolled Epilepsy
History Of Post Op Delirium
History Of DVT (Therapeutic Use Of Anti-Coagulants)
Chronic Alcoholism
Chronic Smoker (1 Pack/Day Past Six Months)
History of allergy to local anaesthetics.
Cardiopulmonary Disease (Recent MI,S/P Cardio Thoracic Surgery, severe pulmonary artery hypertension,Arrythmias, ejection fraction< 40%)

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the effect of addition of ultrasound guided genicular nerve block to anaesthetic techniques on postoperative pain in patients undergoing total knee replacement.
 
To compare the effect of addition of ultrasound guided genicular nerve block to anaesthetic techniques on postoperative pain in patients undergoing total knee replacement.
Pain will be assessed at 6 12 18 24 & 48 hourly postoperatively by an anesthesiologist  
 
Secondary Outcome  
Outcome  TimePoints 
To compare the effect of addition of ultrasound guided genicular nerve blocks in patients undergoing total knee replacement on postoperative opioid requirement , ambulation & physiotherapy   Post operative opioid consumption will be recorded during 0-6 hours, 6-12 hours,12-24 hours & 24-48 hours.

Ambulation distance was measured in feet on day 0, day 1, day 2 and day 3.

Proportion of patients receiving rescue analgesia in both groups will also be compared.
Presence of motor weakness of quadriceps if any will be noted.
 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   25/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Total knee arthroplasty (TKA) is a common surgical procedure that is characterized by moderate to severe postoperative pain .

Severe pain post operatively has been known to have detrimental impact  on patient outcome  and morbidity.

Several modalities of analgesia including  nerve blocks for effective postoperative analgesia and faster functional recovery have been discussed in the literature.

Ultrasound guided genicular nerve blocks  and radio-frequency ablation are known to provide  effective analgesia in chronic knee pain.

In this study, we aim to assess the analgesic  efficacy of combination of genicular nerve  blocks and adductor canal  block in primary total knee arthroplasty

This technique for analgesia in  TKA patients can be utilized to improve pain scores and  facilitate early ambulation, reduce the use of opioids in perioperative period.

 
Close